Cargando…

Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence

The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress markers indicative of increased unfolded protein response (UPR) signaling is no longer in doubt. However, what remains controversial is whether this increase in ER stress response actually contributes importantl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Neha, De Franco, Elisa, Arvan, Peter, Cnop, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101261/
https://www.ncbi.nlm.nih.gov/pubmed/33967960
http://dx.doi.org/10.3389/fendo.2021.650158
_version_ 1783688936403501056
author Shrestha, Neha
De Franco, Elisa
Arvan, Peter
Cnop, Miriam
author_facet Shrestha, Neha
De Franco, Elisa
Arvan, Peter
Cnop, Miriam
author_sort Shrestha, Neha
collection PubMed
description The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress markers indicative of increased unfolded protein response (UPR) signaling is no longer in doubt. However, what remains controversial is whether this increase in ER stress response actually contributes importantly to the β-cell failure of type 2 diabetes (akin to ‘terminal UPR’), or whether it represents a coping mechanism that represents the best attempt of β-cells to adapt to changes in metabolic demands as presented by disease progression. Here an intercontinental group of experts review evidence for the role of ER stress in monogenic and type 2 diabetes in an attempt to reconcile these disparate views. Current evidence implies that pancreatic β-cells require a regulated UPR for their development, function and survival, as well as to maintain cellular homeostasis in response to protein misfolding stress. Prolonged ER stress signaling, however, can be detrimental to β-cells, highlighting the importance of “optimal” UPR for ER homeostasis, β-cell function and survival.
format Online
Article
Text
id pubmed-8101261
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81012612021-05-07 Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence Shrestha, Neha De Franco, Elisa Arvan, Peter Cnop, Miriam Front Endocrinol (Lausanne) Endocrinology The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress markers indicative of increased unfolded protein response (UPR) signaling is no longer in doubt. However, what remains controversial is whether this increase in ER stress response actually contributes importantly to the β-cell failure of type 2 diabetes (akin to ‘terminal UPR’), or whether it represents a coping mechanism that represents the best attempt of β-cells to adapt to changes in metabolic demands as presented by disease progression. Here an intercontinental group of experts review evidence for the role of ER stress in monogenic and type 2 diabetes in an attempt to reconcile these disparate views. Current evidence implies that pancreatic β-cells require a regulated UPR for their development, function and survival, as well as to maintain cellular homeostasis in response to protein misfolding stress. Prolonged ER stress signaling, however, can be detrimental to β-cells, highlighting the importance of “optimal” UPR for ER homeostasis, β-cell function and survival. Frontiers Media S.A. 2021-04-22 /pmc/articles/PMC8101261/ /pubmed/33967960 http://dx.doi.org/10.3389/fendo.2021.650158 Text en Copyright © 2021 Shrestha, De Franco, Arvan and Cnop https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Shrestha, Neha
De Franco, Elisa
Arvan, Peter
Cnop, Miriam
Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
title Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
title_full Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
title_fullStr Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
title_full_unstemmed Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
title_short Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
title_sort pathological β-cell endoplasmic reticulum stress in type 2 diabetes: current evidence
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101261/
https://www.ncbi.nlm.nih.gov/pubmed/33967960
http://dx.doi.org/10.3389/fendo.2021.650158
work_keys_str_mv AT shresthaneha pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence
AT defrancoelisa pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence
AT arvanpeter pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence
AT cnopmiriam pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence